Mai Volker, Draganov Peter V
Department of Gastroenterology, Hepatology and Nutrition, University of Florida, Gainesville, Florida 32610, USA.
World J Gastroenterol. 2009 Jan 7;15(1):81-5. doi: 10.3748/wjg.15.81.
The complex gut microbial flora harbored by individuals (microbiota) has long been proposed to contribute to intestinal health as well as disease. Pre- and probiotic products aimed at improving health by modifying microbiota composition have already become widely available and acceptance of these products appears to be on the rise. However, although required for the development of effective microbiota based interventions, our basic understanding of microbiota variation on a population level and its dynamics within individuals is still rudimentary. Powerful new parallel sequence technologies combined with other efficient molecular microbiota analysis methods now allow for comprehensive analysis of microbiota composition in large human populations. Recent findings in the field strongly suggest that microbiota contributes to the development of obesity, atopic diseases, inflammatory bowel diseases and intestinal cancers. Through the ongoing National Institutes of Health Roadmap 'Human Microbiome Project' and similar projects in other parts of the world, a large coordinated effort is currently underway to study how microbiota can impact human health. Translating findings from these studies into effective interventions that can improve health, possibly personalized based on an individuals existing microbiota, will be the task for the next decade(s).
长期以来,人们一直认为个体所携带的复杂肠道微生物群落(微生物群)对肠道健康以及疾病都有影响。旨在通过改变微生物群组成来改善健康的益生元和益生菌产品已广泛可得,而且这些产品的接受度似乎在上升。然而,尽管对于开发基于微生物群的有效干预措施来说这是必要的,但我们对人群水平上微生物群变异及其在个体内的动态变化的基本理解仍然很初步。强大的新型平行测序技术与其他高效的分子微生物群分析方法相结合,现在能够对大量人群的微生物群组成进行全面分析。该领域最近的研究结果强烈表明,微生物群与肥胖症、过敏性疾病、炎症性肠病和肠道癌症的发生有关。通过美国国立卫生研究院正在进行的“人类微生物组计划”以及世界其他地区的类似项目,目前正在开展一项大规模的协调研究工作,以探究微生物群如何影响人类健康。将这些研究结果转化为能够改善健康的有效干预措施,可能基于个体现有的微生物群进行个性化定制,这将是未来几十年的任务。